Matthew Weinberg Writes for Tobacco Reporter

June 17, 2014

CEO Matthew Weinberg writes for Tobacco Reporter Magazine encouraging stakeholders to take advantage of the opportunity to respond to FDA e-cigarette regulations.

April 23, 2012

CEO Matthew Weinberg Presents at FDA Clinical Trials Hearing

April 23 - The Weinberg Group CEO, Matthew Weinberg, presented today at FDA’s hearing titled “Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice.” Mr. Weinberg...

Read the Full Article

February 11, 2014

Drug Companies Face Stricter Clinical Trial Regulation Worldwide

For more information on The Weinberg Group’s independent clinical auditing services, please contact Jeff Antos at or 202.280.0815.

Read the Full Article

November 25, 2014

Matthew Weinberg Quoted in Article about EMA’s Initiative to Broaden Expert Involvement with Updated Policy on Conflicts of Interest

FDANews Drug Industry Daily Nov. 21, 2014 Europe’s drug regulatory agency has revised the conflict of interest policy for its scientific committee members and experts, a move that one attorney says...

Read the Full Article